nodes	percent_of_prediction	percent_of_DWPC	metapath
Carteolol—Respiratory failure—Fludarabine—lymphatic system cancer	0.0382	0.0382	CcSEcCtD
Carteolol—Diabetic—Methotrexate—lymphatic system cancer	0.0333	0.0333	CcSEcCtD
Carteolol—Depression—Mechlorethamine—lymphatic system cancer	0.0323	0.0323	CcSEcCtD
Carteolol—Cardiac failure congestive—Fludarabine—lymphatic system cancer	0.03	0.03	CcSEcCtD
Carteolol—Visual disturbance—Fludarabine—lymphatic system cancer	0.0287	0.0287	CcSEcCtD
Carteolol—Cerebrovascular accident—Fludarabine—lymphatic system cancer	0.0278	0.0278	CcSEcCtD
Carteolol—Bronchospasm—Teniposide—lymphatic system cancer	0.0263	0.0263	CcSEcCtD
Carteolol—Respiratory failure—Vincristine—lymphatic system cancer	0.0233	0.0233	CcSEcCtD
Carteolol—Cerebrovascular accident—Bleomycin—lymphatic system cancer	0.0204	0.0204	CcSEcCtD
Carteolol—Diabetes mellitus—Carmustine—lymphatic system cancer	0.02	0.02	CcSEcCtD
Carteolol—Sinusitis—Fludarabine—lymphatic system cancer	0.0197	0.0197	CcSEcCtD
Carteolol—Arrhythmia—Teniposide—lymphatic system cancer	0.0191	0.0191	CcSEcCtD
Carteolol—Visual impairment—Fludarabine—lymphatic system cancer	0.0181	0.0181	CcSEcCtD
Carteolol—Cardiac failure congestive—Mitoxantrone—lymphatic system cancer	0.0179	0.0179	CcSEcCtD
Carteolol—Diplopia—Carmustine—lymphatic system cancer	0.0174	0.0174	CcSEcCtD
Carteolol—Bronchospasm—Bleomycin—lymphatic system cancer	0.017	0.017	CcSEcCtD
Carteolol—Arrhythmia—Fludarabine—lymphatic system cancer	0.0168	0.0168	CcSEcCtD
Carteolol—Oedema—Teniposide—lymphatic system cancer	0.0152	0.0152	CcSEcCtD
Carteolol—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.0152	0.0152	CcSEcCtD
Carteolol—Hypotension—Teniposide—lymphatic system cancer	0.0142	0.0142	CcSEcCtD
Carteolol—Dyspnoea—Teniposide—lymphatic system cancer	0.0136	0.0136	CcSEcCtD
Carteolol—Depression—Carmustine—lymphatic system cancer	0.0134	0.0134	CcSEcCtD
Carteolol—Oedema—Fludarabine—lymphatic system cancer	0.0134	0.0134	CcSEcCtD
Carteolol—Depression—Vincristine—lymphatic system cancer	0.0128	0.0128	CcSEcCtD
Carteolol—Nausea—Mechlorethamine—lymphatic system cancer	0.0123	0.0123	CcSEcCtD
Carteolol—Conjunctivitis—Mitoxantrone—lymphatic system cancer	0.0121	0.0121	CcSEcCtD
Carteolol—Dyspnoea—Fludarabine—lymphatic system cancer	0.0119	0.0119	CcSEcCtD
Carteolol—Sinusitis—Mitoxantrone—lymphatic system cancer	0.0117	0.0117	CcSEcCtD
Carteolol—Visual impairment—Carmustine—lymphatic system cancer	0.0116	0.0116	CcSEcCtD
Carteolol—Bradycardia—Mitoxantrone—lymphatic system cancer	0.0114	0.0114	CcSEcCtD
Carteolol—Respiratory failure—Methotrexate—lymphatic system cancer	0.0113	0.0113	CcSEcCtD
Carteolol—Hypersensitivity—Teniposide—lymphatic system cancer	0.0112	0.0112	CcSEcCtD
Carteolol—Asthenia—Teniposide—lymphatic system cancer	0.0109	0.0109	CcSEcCtD
Carteolol—Arrhythmia—Carmustine—lymphatic system cancer	0.0108	0.0108	CcSEcCtD
Carteolol—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.01	0.01	CcSEcCtD
Carteolol—Vision blurred—Carmustine—lymphatic system cancer	0.00989	0.00989	CcSEcCtD
Carteolol—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00986	0.00986	CcSEcCtD
Carteolol—Oedema—Bleomycin—lymphatic system cancer	0.00981	0.00981	CcSEcCtD
Carteolol—Asthenia—Fludarabine—lymphatic system cancer	0.0096	0.0096	CcSEcCtD
Carteolol—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00955	0.00955	CcSEcCtD
Carteolol—Headache—Teniposide—lymphatic system cancer	0.00954	0.00954	CcSEcCtD
Carteolol—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.00928	0.00928	CcSEcCtD
Carteolol—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00919	0.00919	CcSEcCtD
Carteolol—Hypotension—Bleomycin—lymphatic system cancer	0.00917	0.00917	CcSEcCtD
Carteolol—Nausea—Teniposide—lymphatic system cancer	0.00904	0.00904	CcSEcCtD
Carteolol—Dyspnoea—Bleomycin—lymphatic system cancer	0.00875	0.00875	CcSEcCtD
Carteolol—Oedema—Carmustine—lymphatic system cancer	0.00856	0.00856	CcSEcCtD
Carteolol—Visual disturbance—Methotrexate—lymphatic system cancer	0.00852	0.00852	CcSEcCtD
Carteolol—Headache—Fludarabine—lymphatic system cancer	0.00838	0.00838	CcSEcCtD
Carteolol—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.00823	0.00823	CcSEcCtD
Carteolol—Oedema—Vincristine—lymphatic system cancer	0.00817	0.00817	CcSEcCtD
Carteolol—Hypotension—Carmustine—lymphatic system cancer	0.008	0.008	CcSEcCtD
Carteolol—Oedema—Mitoxantrone—lymphatic system cancer	0.00796	0.00796	CcSEcCtD
Carteolol—Nausea—Fludarabine—lymphatic system cancer	0.00795	0.00795	CcSEcCtD
Carteolol—Shock—Mitoxantrone—lymphatic system cancer	0.00783	0.00783	CcSEcCtD
Carteolol—Insomnia—Carmustine—lymphatic system cancer	0.00774	0.00774	CcSEcCtD
Carteolol—Hypotension—Vincristine—lymphatic system cancer	0.00764	0.00764	CcSEcCtD
Carteolol—Dyspnoea—Carmustine—lymphatic system cancer	0.00763	0.00763	CcSEcCtD
Carteolol—Hypotension—Mitoxantrone—lymphatic system cancer	0.00744	0.00744	CcSEcCtD
Carteolol—Insomnia—Vincristine—lymphatic system cancer	0.00739	0.00739	CcSEcCtD
Carteolol—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00723	0.00723	CcSEcCtD
Carteolol—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.0071	0.0071	CcSEcCtD
Carteolol—Asthenia—Bleomycin—lymphatic system cancer	0.00704	0.00704	CcSEcCtD
Carteolol—Hypersensitivity—Carmustine—lymphatic system cancer	0.00631	0.00631	CcSEcCtD
Carteolol—Depression—Methotrexate—lymphatic system cancer	0.0062	0.0062	CcSEcCtD
Carteolol—Asthenia—Carmustine—lymphatic system cancer	0.00614	0.00614	CcSEcCtD
Carteolol—Conjunctivitis—Methotrexate—lymphatic system cancer	0.00604	0.00604	CcSEcCtD
Carteolol—Hypersensitivity—Vincristine—lymphatic system cancer	0.00602	0.00602	CcSEcCtD
Carteolol—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00587	0.00587	CcSEcCtD
Carteolol—Asthenia—Vincristine—lymphatic system cancer	0.00586	0.00586	CcSEcCtD
Carteolol—Nausea—Bleomycin—lymphatic system cancer	0.00583	0.00583	CcSEcCtD
Carteolol—Asthenia—Mitoxantrone—lymphatic system cancer	0.00571	0.00571	CcSEcCtD
Carteolol—Dizziness—Carmustine—lymphatic system cancer	0.00566	0.00566	CcSEcCtD
Carteolol—Dizziness—Vincristine—lymphatic system cancer	0.00541	0.00541	CcSEcCtD
Carteolol—Visual impairment—Methotrexate—lymphatic system cancer	0.00538	0.00538	CcSEcCtD
Carteolol—Headache—Carmustine—lymphatic system cancer	0.00536	0.00536	CcSEcCtD
Carteolol—Headache—Vincristine—lymphatic system cancer	0.00512	0.00512	CcSEcCtD
Carteolol—Nausea—Carmustine—lymphatic system cancer	0.00509	0.00509	CcSEcCtD
Carteolol—Headache—Mitoxantrone—lymphatic system cancer	0.00499	0.00499	CcSEcCtD
Carteolol—Nausea—Vincristine—lymphatic system cancer	0.00486	0.00486	CcSEcCtD
Carteolol—Dysgeusia—Methotrexate—lymphatic system cancer	0.00476	0.00476	CcSEcCtD
Carteolol—Nausea—Mitoxantrone—lymphatic system cancer	0.00473	0.00473	CcSEcCtD
Carteolol—Vision blurred—Methotrexate—lymphatic system cancer	0.00458	0.00458	CcSEcCtD
Carteolol—Hypotension—Methotrexate—lymphatic system cancer	0.00371	0.00371	CcSEcCtD
Carteolol—Insomnia—Methotrexate—lymphatic system cancer	0.00359	0.00359	CcSEcCtD
Carteolol—Dyspnoea—Methotrexate—lymphatic system cancer	0.00354	0.00354	CcSEcCtD
Carteolol—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00292	0.00292	CcSEcCtD
Carteolol—Asthenia—Methotrexate—lymphatic system cancer	0.00285	0.00285	CcSEcCtD
Carteolol—Dizziness—Methotrexate—lymphatic system cancer	0.00262	0.00262	CcSEcCtD
Carteolol—Headache—Methotrexate—lymphatic system cancer	0.00248	0.00248	CcSEcCtD
Carteolol—Nausea—Methotrexate—lymphatic system cancer	0.00236	0.00236	CcSEcCtD
